XML 46 R30.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY INCENTIVE PLAN (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity

A summary of the stock option activity under the Hyperfine Plan is presented in the table below:

 

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

 

Aggregate Intrinsic Value

 

Outstanding at January 1, 2021

 

 

1,903,479

 

 

$

0.87

 

 

7.07

 

 

$

2,073

 

Granted

 

 

6,771,237

 

 

 

3.37

 

 

 

 

 

 

 

Exercised

 

 

(565,533

)

 

 

2.65

 

 

 

 

 

 

 

Forfeited

 

 

(587,047

)

 

 

3.86

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

7,522,136

 

 

$

3.21

 

 

 

8.79

 

 

$

30,052

 

Options exercisable at December 31, 2021

 

 

2,332,624

 

 

$

2.98

 

 

 

7.82

 

 

$

9,785

 

Vested and expected to vest at December 31, 2021

 

 

7,117,220

 

 

$

3.20

 

 

 

8.77

 

 

$

28,445

 

Assumptions Used to Value Option Grants to Employees and Nonemployees The assumptions used to value option grants to employees and nonemployees for the years ended December 31, 2021 and 2020 were as follows:

 

 

 

2021

 

2020

Risk Free interest rate

 

0.95% - 1.13%

 

1.5% - 1.7%

Expected dividend yield

 

0%

 

0%

Expected term

 

5.40 years - 6.17 years

 

5.8 years - 6.0 years

Expected volatility

 

70%

 

60%

Summary of Stock Options Granted

The stock options granted to the Company's employees and nonemployees for the periods presented were as follows:

 

 

 

2021

 

 

2020

 

Stock options granted to employee

 

 

3,534,844

 

 

 

897,240

 

Stock options granted to nonemployee

 

 

3,236,393

 

 

 

284,816

 

Total stock options granted

 

 

6,771,237

 

 

 

1,182,056

 

Key Assumptions Used in Valuation for Earn-Out Shares The key assumptions used in the valuation were as follows:

 

 

 

2021

 

Stock Price

 

10.92

 

Risk Free interest rate

 

 

0.96

%

Expected dividend yield

 

 

0.0

%

Term (years)

 

3

 

Expected volatility

 

 

54.5

%

Summary of Stock-Based Compensation Expense

The Company’s stock-based compensation expense for the periods presented was as follows:

 

 

 

2021

 

 

2020

 

Cost of sales - Device

 

$

12

 

 

$

 

Cost of sales - Service

 

 

12

 

 

 

 

Research and development

 

 

1,327

 

 

 

864

 

General and administrative

 

 

5,482

 

 

 

231

 

Sales and marketing

 

 

68

 

 

 

22

 

Total stock-based compensation expense

 

$

6,901

 

 

$

1,117